Company Filing History:
Years Active: 1989-1992
Title: Jon P Schaumann: Innovator in Monoclonal Antibody Research
Introduction
Jon P Schaumann is a notable inventor in the field of biomedical research, particularly known for his work on monoclonal antibodies. His contributions have significantly advanced the understanding and application of tissue plasminogen activator (t-PA) in medical science. Despite having no patents attributed to him, his research has been influential in the development of therapeutic techniques.
Latest Patents
Schaumann's latest patents include two significant works. The first is titled "Monoclonal Antibody Specific For Human Colon Fibroblast-Derived T-Pa," which focuses on a monoclonal antibody that is specific for human colon fibroblast-derived t-PA. This invention is particularly useful for immunoaffinity chromatography purification of t-PA and for determining t-PA levels in biological samples. The second patent is "Large Scale Production Of Plasminogen Activator From Normal Human Colon Cells," which discusses the extraction of plasminogen activators from cultured normal human colon cells, adaptable for large-scale production. This research highlights the chemical differences between the purified t-PA obtained from normal human colon fibroblast cells and that from Bowes melanoma.
Career Highlights
Throughout his career, Jon P Schaumann has worked alongside prominent figures in the field, contributing to significant advancements in medical research. His work has been recognized for its potential applications in therapeutic settings, particularly in the treatment of conditions related to blood clotting and tissue repair.
Collaborations
Schaumann has collaborated with notable researchers such as Joseph Feder, enhancing the impact of his work through shared expertise and innovative approaches.
Conclusion
Jon P Schaumann's contributions to the field of monoclonal antibody research demonstrate his commitment to advancing medical science. His innovative work continues to influence the development of therapeutic techniques that can improve patient outcomes.